|
| Press Releases |
|
 |
|
| Thursday, March 7, 2024 |
|
|
Lexaria Awards Contract For Next GLP-1 Human Pilot Study |
| Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces it has hired a contract research organization ("CRO") to perform the Company's second DehydraTECH-powered glucagon-like peptide 1 ("GLP-1") human pilot study #2 (the "Study"). more info >> |
|
| Tuesday, March 5, 2024 |
|
|
Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1 |
| more info >> |
|
| Monday, March 4, 2024 |
|
|
7% Weight Loss in Animals Supports Lexaria's Next 8-week Animal Study |
| more info >> |
|
| Friday, March 1, 2024 |
|
|
Lexaria Announces FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial |
| Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW), a global innovator in drug delivery platforms, announces that the U.S. Food and Drug Administration (FDA) has confirmed effectiveness as of February 28, 2024 of the Company's investigational new drug (IND) application thereby cleared for Lexaria to conduct its planned U.S. Phase 1b hypertension clinical trial HYPER-H23-1 utilizing DehydraTECH-CBD. more info >> |
|
| Saturday, February 17, 2024 |
|
|
Lexaria Announces Closing of $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules |
| more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TANAKA Develops World's First High-Performance Palladium Hydrogen Permeable Membrane Exhibiting High Hydrogen Purification Performance at Temperatures around 100 degrees C
Mar 5, 2026 22:00 JST
|
|
|
美國馬球協會擴大大學合作計畫 2026賽季隊伍數創紀錄達70支
Mar 5, 2026 20:00 HKT/SGT
|
|
|
美国马球协会扩大大学合作计划，2026赛季参赛队伍创纪录达70支
Mar 5, 2026 20:00 HKT/SGT
|
|
|
U.S. Polo Assn. Expands Collegiate Partnership Program to Record 70 Teams for 2026 Season
Mar 5, 2026 20:00 HKT/SGT
|
|
|
Lancaster Resources Announces Resignation of Penny White and the Addition of Rob Heaslop to the Board of Directors
Mar 5, 2026 17:29 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
Mar 5, 2026 17:00: JST
|
|
|
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
Mar 5, 2026 16:00 HKT/SGT
|
|
|
Honda to Begin Sales of Two U.S.-built Vehicles in Japan
Mar 5, 2026 16:47 JST
|
|
|
DOCOMO's New Haptic-sharing System Enables Fans to Feel Closer to Idols
Mar 5, 2026 16:38 JST
|
|
|
Galaxy Corporation Leads "K-Entertech" IPO Rush as Nasdaq Vice Chairman's Surprise Visit Boosts Listing Prospects
Mar 5, 2026 15:30 HKT/SGT
|
|
|
康哲药业自研INHBE小核酸药物获批超重/肥胖临床
Mar 5, 2026 15:13 HKT/SGT
|
|
|
康哲藥業自研INHBE小核酸藥物獲批超重/肥胖臨床
Mar 5, 2026 15:02 HKT/SGT
|
|
|
Formerra 任命 Tom Kelly 為首席執行官
Mar 5, 2026 14:11 HKT/SGT
|
|
|
富士通Japan、大分市民図書館において「デジタル認証アプリ」を活用したWeb利用者登録サービスを構築し、運用を開始
Mar 5, 2026 13:25: JST
|
|
|
Honda、米国生産乗用車の日本導入を決定
Mar 5, 2026 12:50: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
